- Home
- KALV vs DPG Comparison
KALV vs DPG Comparison
Compare KALV & DPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- DPG
- Stock Information
- Founded
- KALV N/A
- DPG 2011
- Country
- KALV United States
- DPG United States
- Employees
- KALV N/A
- DPG N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- DPG Trusts Except Educational Religious and Charitable
- Sector
- KALV Health Care
- DPG Finance
- Exchange
- KALV Nasdaq
- DPG Nasdaq
- Market Cap
- KALV 642.3M
- DPG 450.4M
- IPO Year
- KALV N/A
- DPG N/A
- Fundamental
- Price
- KALV $14.31
- DPG $12.47
- Analyst Decision
- KALV Strong Buy
- DPG
- Analyst Count
- KALV 9
- DPG 0
- Target Price
- KALV $26.29
- DPG N/A
- AVG Volume (30 Days)
- KALV 2.0M
- DPG 150.1K
- Earning Date
- KALV 07-10-2025
- DPG 01-01-0001
- Dividend Yield
- KALV N/A
- DPG 9.09%
- EPS Growth
- KALV N/A
- DPG N/A
- EPS
- KALV N/A
- DPG N/A
- Revenue
- KALV N/A
- DPG N/A
- Revenue This Year
- KALV N/A
- DPG N/A
- Revenue Next Year
- KALV $347.19
- DPG N/A
- P/E Ratio
- KALV N/A
- DPG N/A
- Revenue Growth
- KALV N/A
- DPG N/A
- 52 Week Low
- KALV $7.30
- DPG $7.90
- 52 Week High
- KALV $16.32
- DPG $13.58
- Technical
- Relative Strength Index (RSI)
- KALV 58.58
- DPG 60.67
- Support Level
- KALV $11.10
- DPG $12.13
- Resistance Level
- KALV $16.32
- DPG $12.45
- Average True Range (ATR)
- KALV 1.10
- DPG 0.17
- MACD
- KALV 0.36
- DPG 0.01
- Stochastic Oscillator
- KALV 68.95
- DPG 65.87
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About DPG Duff & Phelps Utility and Infrastructure Fund Inc.
Duff & Phelps Utility & Infrastructure Fund Inc. is an investment fund. Its investment objective is to seek total return, resulting from a high level of current income, with an emphasis on providing tax-advantaged dividend income.